10X GENOMICS XENIUM PRIME 5K REAGENTS (AMBIS 2261543)
SAM.GOV Due: May 22, 2025 at 02:00 PM UTC
In-Active Combined Synopsis/Solicitation Source Url

Summary

The opportunity involves the procurement of 10X Genomics Xenium Prime 5K reagents for the National Institutes of Health (NIH), specifically for the National Institute of Allergy and Infectious Diseases (NIAID). This acquisition is part of ongoing research aimed at understanding immune function and the body's response to viral infections, particularly in relation to autoimmune diseases. The work requires a contractor capable of supplying specific reagents and kits that will be used in sequencing and analyzing samples from patients with rare diseases. Businesses with expertise in biological product manufacturing and a focus on commercial items are encouraged to bid on this opportunity, as it is being processed under Simplified Acquisition Procedures.
Description

This notice is a Combined Synopsis/Solicitation for commercial items using Simplified Acquisition Procedures. This acquisition will be made in accordance with the format in Federal Acquisition Regulation (FAR) Subpart 12.6 “Streamlined Procedures for Evaluation and solicitation for commerci

Entities
HAHSDO
Department of Health and Human Services
NIOH
National Institutes of Health
NAICS
325414
Set Aside
None
Place of Performance
Bethesda , Maryland 20892
Point of Contact
Full Name Email Phone Type
RITA DAVIS [email protected] 3017617461 primary
Tonia Alexander [email protected] 2406695124 secondary
Attachments
  • RFQ-NIAID-25-2261543_FAR_52.212-5_Terms+and+Conditions.pdf